胶原蛋白填充剂入局者激增，三类注册证不再是稀缺资源

Core Viewpoint - The collagen filler market is experiencing increased competition, leading to concerns about maintaining high profit margins as more products enter the market [2][3]. Market Dynamics - Companies like Qipu Bio and Juzi Bio have recently received Class III medical device registration for their collagen fillers, contributing to a total of nine products approved since last year, surpassing previous totals [3]. - Collagen fillers are gaining popularity as a non-invasive option for facial enhancement, similar to hyaluronic acid, with some companies reporting gross profit margins exceeding 80% [3]. - The influx of collagen fillers may lead to price wars, similar to the hyaluronic acid market, which could pressure company performance [3][4]. Competitive Landscape - The increasing number of manufacturers in the collagen filler space is seen as beneficial for market growth but poses risks to profit margins due to potential price competition [4]. - Experts suggest that the focus should shift back to clinical efficacy and long-term value rather than short-term price competition [4]. Consumer Insights - Consumer satisfaction in high-end medical aesthetics is centered around "natural effects" and "duration," while price-sensitive users are becoming more prevalent in lower-tier markets [5]. - The core consumer understanding is evolving to consider age, problem areas, and budget when selecting brands [5]. Industry Evolution - The industry is transitioning from a phase of rapid, unregulated growth to a more mature and standardized market, with consumers willing to pay for quality rather than just price [5][6]. - Companies are investing in research and development to innovate beyond traditional manufacturing processes, aiming for breakthroughs in collagen technology [6].